WHO backs antibody treatment for high-risk Covid patients

0
188

PARIS, France (AFP) — The World Health Organization (WHO) on Friday recommended the synthetic antibody treatment Regeneron for Covid-19, but only in patients with specific health profiles. Persons with non-severe Covid-19 who are nonetheless at high risk of hospitalization can take the antibody combo, as should critically ill patients unable to mount an adequate immune response, according to a WHO finding published in BMJ. Regeneron is only the third treatment for Covid to be recommended […]